The U.S. Food and Drug Administration (FDA), Dec. 13, issued regulations allowing drug companies to suggest pediatric drug doses without performing clinical trials on children.

The new rule amends a 1979 regulation which required full clinical trials of adult drugs on children before age-appropriate dosing could be suggested, according to an FDA statement. The new rule allows companies, in some situations, to use information from adult clinical trials and other research to provide dosing information.

This content is only available via PDF.
You do not currently have access to this content.